Stock overview
Rapport Therapeutics, Inc.
Explore the company, reported ownership, price history, and available source evidence.
Rapport Therapeutics, Inc. (RAPP) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $33.91
- · RAPP
- Tracked holders
- 1 fund
- Latest available 13F per fund
RAPP · USD
Price
$33.91
+$13.11
(+63.03%)
over selected range
Close · Sep 25, 2026
Market closed
577 stored daily closes
$33.91
Sep 25, 2026
- Range low
- $7.15
- Range high
- $52.50
- Observations
- 577
- Session date
- Sep 25, 2026
Jun 7, 2024–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $64,467,240 | 0.32% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market